Dengue is a growing concern in Cuba, with 2.5 billion people around the world living at risk of contracting the disease. The incidence of dengue is particularly high in tropical countries like Cuba, where mosquito infestation rates skyrocket during summer and autumn. The situation in Cuba has become increasingly complex due to the recent transmission peak, which coincided with a deep economic crisis in the country. While Cuban scientists are currently working on a dengue vaccine candidate based on a safe technological platform, the development process is ongoing. Nonetheless, the impending availability of a rapid diagnosis system for dengue is a beacon of hope for early detection and appropriate treatment. The top five most important keywords from the content are “dengue, Cuba, vaccine candidate, safe technological platform, and rapid diagnosis system”.
Safety of Cuban Dengue Vaccine Candidate’s Technological Platform Validated
The Center for Genetic Engineering and Biotechnology (CIGB) reported on Tuesday that the dengue vaccine candidate being developed in Cuba has a safe technological platform. The possible drug is based on recombinant proteins, which is a safe technological platform, according to a dispatch from Prensa Latina news agency.
The CIGB’s Twitter account states that the center’s experts have a tetravalent candidate, based on proteins from the four dengue viruses, which is currently in the evaluation phase. The aim of the drug is to lower the level of dengue virus infection (viral load) to avoid severity and symptoms.
The development of the vaccine is a complex process, and it is necessary to immunize against each of the four serotypes of dengue at the same time for the product to be effective. However, obtaining the vaccine is a significant step in preventing the disease.
A new rapid diagnosis system for dengue is expected to be available in the course of 2023, according to PL. This system will allow specialists from the Immunoassay Center to determine, upon the appearance of the first symptoms, whether it is dengue or a second infection. This will serve to apply a differentiated treatment to patients, and avoid the worsening of the disease and death, Eduardo Martínez, president of the Biotechnological and Pharmaceutical Industries Business Group, argued.
Dengue is a disease transmitted through the bite of an infected Aedes aegypti mosquito and causes symptoms ranging from mild to severe, including headaches, muscle and joint pain, and erythema fever.
In conclusion, the CIGB’s development of a safe technological platform for the Cuban dengue vaccine candidate is a significant milestone in combating this deadly disease. With the evaluation phase currently underway, it remains to be seen when the vaccine will be made available to the public. Nonetheless, the impending availability of a rapid diagnosis system for dengue serves as a beacon of hope for those who are afflicted with the disease, as it allows for early detection and the application of the appropriate treatment.
Dengue: A Growing Concern in Cuba
Dengue is a disease that affects millions of people around the world, with 2.5 billion people living at risk of getting it. In tropical countries like Cuba, where mosquito infestation rates skyrocket during summer and autumn, the incidence of the disease can be particularly high. In its most serious cases, dengue can cause death.
The situation in Cuba has become increasingly complex due to the recent transmission peak, which coincided with a deep economic crisis in the country. This has made it difficult to acquire supplies and carry out necessary actions to mitigate the risks and treat the sick. In July 2022, the Ministry of Public Health reported that Cuba had broken the record for the number of reproduction points of the dengue-transmitting mosquito for the second year in 15 years. In September, the head of the ministry confirmed the transmission of the virus in all 15 provinces and warned about the high infestation rates of the transmitting agent.
It is clear that dengue is a growing concern in Cuba, and the development of a safe and effective vaccine is crucial to combat the disease. Cuban scientists are currently working on a dengue vaccine candidate, based on a safe technological platform. While the development process is complex and ongoing, the impending availability of a rapid diagnosis system for dengue is a beacon of hope for early detection and appropriate treatment.
Don’t miss interesting posts on Famousbio
